VacSYn, NCT06015841: A Study to Evaluate the Effects of ACI-7104.056 Vaccination in Patients With Early Stages of Parkinson's Disease |
|
|
| Recruiting | 2 | 150 | Europe | Placebo, ACI-7104.056 at Dose A, ACI-7104.056 at Dose B (optional), ACI-7104.056 at Dose C (optional) | AC Immune SA, ICON Clinical Research | Parkinson Disease, Parkinson Disease 6, Early-Onset | 01/28 | 01/28 | | |
